Gene · 714
Papers1,427
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,427
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Proteomic profiling links complement activation to thrombosis in JAK2V617F myeloproliferative neoplasms. | Transl Oncol | 2025 | 41101219 | PubTator, text mining | PubMed |
| Complement and local ocular inflammatory response: Chronic immune factors in myopia. | Sci Prog | 2025 | 41002181 | PubTator, text mining | PubMed |
| Distinct spatial transcriptomic patterns of substantia Nigra in Parkinson disease and Parkinsonian subtype of multiple system atrophy. | Acta Neuropathol Commun | 2025 | 40993824 | PubTator, text mining | PubMed |
| scKAN: interpretable single-cell analysis for cell-type-specific gene discovery and drug repurposing via Kolmogorov-Arnold networks. | Genome Biol | 2025 | 40993718 | PubTator, text mining | PubMed |
| Spatiotemporal multi-omics analysis uncovers NAD-dependent immunosuppressive niche triggering early gastric cancer. | Signal Transduct Target Ther | 2025 | 40976783 | PubTator, text mining | PubMed |
| Multiomic Analyses Reveal the Molecular Mechanisms of Arid Adaptation in a Desert Rodent Species. | Mol Biol Evol | 2025 | 40974098 | PubTator, text mining | PubMed |
| Complement profiling of sural nerves in chronic-inflammatory demyelinating polyneuropathy. | Acta Neuropathol | 2025 | 40971018 | PubTator, text mining | PubMed |
| Tumour Single-Cell Bioinformatics: From Immune Profiling to Molecular Dynamics. | J Cell Mol Med | 2025 | 40954554 | PubTator, text mining | PubMed |
| Regional Transcriptomic Architecture of Glioblastoma Reveals NUCB2 as a Key Orchestrator of Tumour Aggression and Immune Dysfunction. | J Cell Mol Med | 2025 | 40913484 | PubTator, text mining | PubMed |
| DECIPHER for learning disentangled cellular embeddings in large-scale heterogeneous spatial omics data. | Nat Commun | 2025 | 40866331 | PubTator, text mining | PubMed |
| An engineered glioblastoma model yields macrophage-secreted drivers of invasion. | JCI Insight | 2025 | 40857405 | PubTator, text mining | PubMed |
| Multiomics integration analysis identifies tumor cell-derived MIF as a therapeutic target and potentiates anti-PD-1 therapy in osteosarcoma. | J Immunother Cancer | 2025 | 40846326 | PubTator, text mining | PubMed |
| Co-occurrence of clonally related follicular lymphoma and histiocytic sarcoma. | Blood Cancer J | 2025 | 40759639 | PubTator, text mining | PubMed |
| Editorial: Community series in the role of complement in health and disease, volume II. | Front Immunol | 2025 | 40746555 | PubTator, text mining | PubMed |
| Identification of a stromal immunosuppressive barrier orchestrated by SPP1+/C1QC+ macrophages and CD8+ exhausted T cells driving gastric cancer immunotherapy resistance. | Front Immunol | 2025 | 40740771 | PubTator, text mining | PubMed |
| Engineering a Lipid Nanoparticle with Atypical Calcium Crystal Structure for Enhanced IFNβ-Mediated Immunotherapy. | Adv Mater | 2025 | 40605669 | PubTator, text mining | PubMed |
| The proteome of circulating extracellular vesicles and their functional effect on platelets vary with the isolation method. | Sci Rep | 2025 | 40594329 | PubTator, text mining | PubMed |
| EGR2 O-GlcNAcylation orchestrates the development of protumoral macrophages to limit CD8+ T cell antitumor responses. | Cell Chem Biol | 2025 | 40499546 | PubTator, text mining | PubMed |
| Single-cell and spatial transcriptomics reveal correlation between RNA methylation-related miRNA risk model and immune infiltration in hepatocellular carcinoma. | Front Oncol | 2025 | 40416872 | PubTator, text mining | PubMed |
| Dysregulations of C1QA, C1QB, C1QC and C5AR1 as candidate biomarkers of vascular dementia. | NPJ Aging | 2025 | 40414977 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/714/papers?page=4